Monday, 8 September 2014

ECTRIMS This week

ECTRIMS/ACTRIMS travels to Boston this year to the home of many MS pharma, even Swiss/German companies have based their MS work there.

Let's look forward to this years meeting. But posts may be erratic

This is when many of your neuros get clued up for treatments available to you. 

They may have some R n R too, but they also use this time to reflect, to set up new collaborations and discuss new ideas. 

However, as the treatment options get bigger the competition gets stronger. I suspect the red queen will be hard at work (Pharma spending more to remain in the same spot) and there are record numbers of bits of work being presented. 

I am sure many of you have been through the ACTRIMS 2014 programme already.

Are there any highlights that you want to know about? -As we can't be in different places at the same time.

Phase I stem cell trials maybe? or the stuff that the companies are doing....However, they have been sending out press releases already, so we know what's coming from them.

5 comments:

  1. Having read your Red Queen post from last year, I am wondering whether any companies took up your suggestion of a 'post it note' stand? somehow I doubt it... Of course, like many others, I will be interested to hear of any new ideas for treating progressive MS

    ReplyDelete
  2. This is the first I have read your Red Queen blog and could not agree more. I just completed a bit of research on the increase of the costs of DMTs since my DX in 2008 and I would like to interview for my blog, the CEO's of Biogen Idec, Genzyme, TEVA, Novartis and others, about the 400%+ increase of the retail cost of their drugs ($10k to $55-60K range for the older ones).

    It's becoming harder and harder to defend Pharma from the conspiracy theorists who believe pharma doesn't want to find a cure so they can continue to make profits off our disease state. Feel free to pass on my contact information so that I might talk to them if you run out of time covering the other stories of the day.

    safe travels!

    ReplyDelete
  3. How will the votes influence policy or practice in relation to the three burning debates and motions you refer to?

    ReplyDelete
  4. It is a debate between neuros there may not be a right or wrong answer, they may be an eye opener.
    Could they change policy? It depends on what the audience get from them...maybe someone will get inspired.

    Todays debate "The only way is Pharma" can a academic neurologist make a case that they can deliver new drugs to people with MS or are they just kidding themselves

    If they can then pharma has competition and it shows the way in which others can follow
    If they can't why are we doing pointless trials that create hope and go no where or is the hope creation enough to justify them. Is industry clueless without academic neurologists input.

    The Progressive Alliance for MS needs to take note of this one and maybe they have something to say before spending millions

    ReplyDelete

Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.